Insulet (PODD) Competitors

Insulet (NASDAQ:PODD) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations.

Do analysts prefer PODD or BDX?

Insulet presently has a consensus target price of $293.94, suggesting a potential upside of 16.51%. Becton, Dickinson and Company has a consensus target price of $272.86, suggesting a potential upside of 31.89%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts clearly believe Becton, Dickinson and Company is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.76
Becton, Dickinson and Company	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is PODD or BDX more profitable?

Insulet has a net margin of 20.19% compared to Becton, Dickinson and Company's net margin of 8.47%. Insulet's return on equity of 24.46% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	20.19%	24.46%	8.33%
Becton, Dickinson and Company	8.47%	15.74%	7.29%

Do insiders & institutionals have more ownership in PODD or BDX?

87.0% of Becton, Dickinson and Company shares are held by institutional investors. 0.5% of Insulet shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor PODD or BDX?

Insulet received 131 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.22% of users gave Insulet an outperform vote while only 62.46% of users gave Becton, Dickinson and Company an outperform vote.

Company	Underperform	Outperform
Insulet	Outperform Votes 735 66.22%	Underperform Votes 375 33.78%
Becton, Dickinson and Company	Outperform Votes 604 62.46%	Underperform Votes 363 37.54%

Which has better valuation & earnings, PODD or BDX?

Becton, Dickinson and Company has higher revenue and earnings than Insulet. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.07B	8.55	$206.30M	$5.79	43.57
Becton, Dickinson and Company	$20.64B	2.88	$1.71B	$6.02	34.37

Does the media prefer PODD or BDX?

In the previous week, Becton, Dickinson and Company had 7 more articles in the media than Insulet. MarketBeat recorded 34 mentions for Becton, Dickinson and Company and 27 mentions for Insulet. Becton, Dickinson and Company's average media sentiment score of 1.33 beat Insulet's score of 0.82 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	12 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	22 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, PODD or BDX?

Insulet has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500.

Summary

Insulet beats Becton, Dickinson and Company on 10 of the 18 factors compared between the two stocks.